This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$35.78
US$ Class I Dist
NAV per share 20.10.2020
£757.1mAUM

AUM 30.09.2020

Holdings
69.88% Active Share
As at 30.09.2020